LRP4 and Congenital myasthenic syndromes: Previous investigations have also demonstrated that mutations in the β3 propeller domain of LRP4, responsible for congenital myasthenic syndrome, modified its binding and the function of its co-receptor MuSK, leading to AChE deficiency in the patient's biopsy14.